United States: Lessons Learned from Inter Partes
Since Inter Partes Reviews (IPR) first became available in September 2012, patent challengers have filed over 2,553 petitions (as of February 28 2015). Yet, only 193 (7.5%) involve biotech- or pharma-related patents assigned to Technology Center 1600 (Life Sciences IPRs). The majority of the...
13/04/2015